Witnessing the stock’s movement on the chart, on April 07, 2021, ProQR Therapeutics N.V. (NASDAQ: PRQR) had a quiet start as it plunged -5.08% to $6.17. During the day, the stock rose to $6.65 and sunk to $6.08 before settling in for the price of $6.50 at the close. Taking a more long-term approach, PRQR posted a 52-week range of $3.40-$9.46.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 23.90%. Meanwhile, its Annual Earning per share during the time was -0.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 32.40%. This publicly-traded company’s shares outstanding now amounts to $50.19 million, simultaneously with a float of $48.63 million. The organization now has a market capitalization sitting at $337.56 million. At the time of writing, stock’s 50-day Moving Average stood at $5.38, while the 200-day Moving Average is $4.93.
ProQR Therapeutics N.V. (PRQR) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. ProQR Therapeutics N.V.’s current insider ownership accounts for 2.37%, in contrast to 62.50% institutional ownership.
ProQR Therapeutics N.V. (PRQR) Earnings and Revenue Records
As on 12/30/2020, Multinational firm has announced its last quarter scores, in which it reported -$0.31 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.29) by -$0.02. This company achieved a return on equity of -60.41. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
ProQR Therapeutics N.V.’s EPS increase for this current 12-month fiscal period is 32.40% and is forecasted to reach -1.34 in the upcoming year.
ProQR Therapeutics N.V. (NASDAQ: PRQR) Trading Performance Indicators
Let’s observe the current performance indicators for ProQR Therapeutics N.V. (PRQR). It’s Quick Ratio in the last reported quarter now stands at 7.80. The Stock has managed to achieve an average true range (ATR) of 0.66. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 30.41.
In the same vein, PRQR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.09, a figure that is expected to reach -0.29 in the next quarter, and analysts are predicting that it will be -1.34 at the market close of one year from today.
Technical Analysis of ProQR Therapeutics N.V. (PRQR)
Going through the that latest performance of [ProQR Therapeutics N.V., PRQR]. Its last 5-days volume of 2.65 million was inferior to the volume of 3.45 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 24.11% While, its Average True Range was 0.71.
Raw Stochastic average of ProQR Therapeutics N.V. (PRQR) in the period of the previous 100 days is set at 45.71%, which indicates a major rise in contrast to 23.67% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 224.16% that was higher than 116.49% volatility it exhibited in the past 100-days period.